Fenwick Represents BASIS Science in $11.75M Financing

By: Ana Razmazma

Fenwick & West LLP represented BASIS Science, Inc., a wrist-based health tracker and online personal dashboard that helps people adopt healthy habits, in its recently announced extension of $11.75 million in Series B funding. The round included investments from Intel Capital, iNovia Capital, Dolby Family Trust, Stanford University and Peninsula-KCG, with participation from existing investors Mayfield Fund, DCM and Norwest Venture Partners. This extension closes the Series B round of funding, which totals more than $23 million.

The new investment will help the company continue to build their strong foundation and offer a great experience for many people looking to build healthy habits. You can also click here for more information on the company’s initial Series B round of funding.

The Fenwick transaction team was led by corporate partner Ted Wang; corporate of counsel In Lee; and corporate associate Ana Razmazma.


Don’t have an account yet?